Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. (DRTS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
drts · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$17.00
Consensus
$13.33
+43.6% upside
Low
$8.00
Median: $15 · Last Close: $9.28
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$13.33
43.6% upside
High Target
$17
83.2%
Low Target
$8
-13.8%
Current Price
$9.28
as of today
Based on analyst price targets, the DRTS stock price prediction for the next 12 months ranges from $8 to $17. The consensus DRTS price forecast of $13.33 implies 43.6% upside from the current price of $9.28.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.88 | ↓ 4.26% |
1-day model range: $8.76–$9.01. Peak: $9.01 (-4.26%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $9 | -0.2% |
| 2028 | $9 | -0.3% |
| 2029 | $9 | -0.4% |
| 2030 | $9 | -0.4% |
| 2031 | — | -0.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DRTS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-06-04 | Barclays | Maintains | Overweight→Overweight |
| 2026-06-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-19 | Piper Sandler | Maintains | Neutral→Neutral |
| 2026-05-12 | Ladenburg Thalmann | Maintains | Buy→Buy |
| 2026-05-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-11 | Citigroup | Maintains | Buy→Buy |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-04 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
Wall Street analysts have recently issued updated ratings on Alpha Tau Medical Ltd. (DRTS) stock. Of the recent 41 rating actions, 0 were upgrades and 1 were downgrades. 6 analysts currently cover DRTS.
Analyst Recommendation Trends
DRTS analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 98.3% YoY
Revenue Next Year
$12M
↑ 910.8% YoY
EPS This Year
$-0.66
EPS Next Year
$-0.51
↓ 21.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast DRTS EPS of $-0.66 for the current fiscal year, based on estimates from 4 analysts. The DRTS revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DRTS stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DRTS price target is $13.33 (+43.6% upside), with an analyst consensus of Buy.
The DRTS short-term stock prediction for tomorrow is $8.88 (-4.26%). The DRTS stock price prediction for 2027 estimates an average of $9. The DRTS stock prediction for 2030 projects a range of $8–$11.
Alpha Tau Medical Ltd. trades on NASDAQ under the ticker DRTS. The DRTS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 83% of covering analysts.
Frequently asked questions
DRTS forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month DRTS price target is $13.33, with a high forecast of $17.00 and a low of $8.00. The median price target is shown in the chart above when available. This implies +43.6% potential upside from the current price of $9.28.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.